My academic training and research experience have provided me with a comprehensive understanding of cancer multidisciplinary approaches, including pathological diagnostics, clinical management, molecular biology, genomics, intratumoral heterogeneity, and bioinformatics. During my PhD program, I gained extensive experience in using Next Generation Sequencing (NGS) to study inter- and intra-patient tumoral genetic heterogeneity. I performed in-depth analysis of somatic mutations, differential gene expression, copy number variation (CNV), tumor clonality, intratumoral heterogeneity, and ploidy scoring based on high throughput data.  Currently, I am engaged in several research projects in the field of cancer genomics, encompassing both fundamental and clinical aspects. In the realm of fundamental research, we are conducting a study that utilizes spatial transcriptomic single-cell sequencing to investigate metastatic cancer and elucidate the mechanisms underlying the tumor microenvironment, which supports the formation of metastases. In the clinical research domain, I am in the process of developing software for NGS analysis and are currently validating the software for the analysis of whole exome sequencing data from tumor-matched normal samples.